Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 2.61 CAD -0.76% Market Closed
Market Cap: 71.6m CAD

Relative Value

The Relative Value of one COV stock under the Base Case scenario is 2.89 CAD. Compared to the current market price of 2.61 CAD, Covalon Technologies Ltd is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

COV Relative Value
Base Case
2.89 CAD
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
79
Median 3Y
2
Median 5Y
1.8
Industry
7.5
Forward
1.9
vs History
4
vs Industry
9
Median 3Y
-6
Median 5Y
-4.5
Industry
23.6
Forward
28.2
vs History
23
vs Industry
10
Median 3Y
-8
Median 5Y
2.2
Industry
20.2
vs History
14
vs Industry
8
Median 3Y
-6.5
Median 5Y
-6.3
Industry
22.9
vs History
50
vs Industry
41
Median 3Y
2.3
Median 5Y
2.3
Industry
2.8
vs History
46
vs Industry
72
Median 3Y
1.6
Median 5Y
1.6
Industry
7.7
Forward
1.4
vs History
58
vs Industry
69
Median 3Y
2.9
Median 5Y
3.1
Industry
9.6
vs History
11
vs Industry
12
Median 3Y
-5.8
Median 5Y
-5
Industry
4.9
Forward
12.7
vs History
11
vs Industry
11
Median 3Y
-5
Median 5Y
-4.5
Industry
4.9
Forward
20.1
vs History
23
vs Industry
12
Median 3Y
-6.3
Median 5Y
1.4
Industry
5.4
vs History
23
vs Industry
8
Median 3Y
-5.1
Median 5Y
1.4
Industry
4
vs History
12
vs Industry
38
Median 3Y
3.4
Median 5Y
2.9
Industry
5.1

Multiples Across Competitors

COV Competitors Multiples
Covalon Technologies Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Covalon Technologies Ltd
XTSX:COV
71.6m CAD 2.1 19.4 11.4 14.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 182 884.2 -162 466.2 -197 285.8 -195 034.5
US
Abbvie Inc
NYSE:ABBV
336.6B USD 5.9 81 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
160.8B USD 4.7 27.1 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
136.8B USD 4.8 22.9 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD 10.9 -122 26 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 060.9 -525.9 -572.7 -557.4
AU
CSL Ltd
ASX:CSL
120.3B AUD 5.2 28.6 17.6 22
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.3B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD 17.9 -156 -699.8 -350.7
P/S Multiple
Revenue Growth P/S to Growth
CA
Covalon Technologies Ltd
XTSX:COV
Average P/S: 3 107 729.1
2.1
13%
0.2
FR
Pharnext SCA
OTC:PNEXF
34 182 884.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.9
10%
1.1
US
E
Epizyme Inc
F:EPE
2 060.9
N/A N/A
AU
CSL Ltd
ASX:CSL
5.2
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
19.9
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.9
30%
0.6
P/E Multiple
Earnings Growth PEG
CA
Covalon Technologies Ltd
XTSX:COV
Average P/E: 32
19.4
17%
1.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 466.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.9
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.6
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Covalon Technologies Ltd
XTSX:COV
Average EV/EBITDA: 15.2
11.4
25%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 285.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.6
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Covalon Technologies Ltd
XTSX:COV
Average EV/EBIT: 19.6
14.4
41%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 034.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.4 N/A N/A
AU
CSL Ltd
ASX:CSL
22
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.7 N/A N/A